CEN Biotech, Inc. filed its 10-K on Apr 14, 2022 for the period ending Dec 31, 2021. In this report its auditor, Mazars, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | -93.75% | -95.45% | -93.33% |
- Stock Market
- Equities
- CENBF Stock
- News CEN Biotech, Inc.
- CEN Biotech, Inc. Auditor Raises 'Going Concern' Doubt